Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
BMC Infectious Diseases|May 4, 2026
Local insights into hepatitis B Virus: genotype distribution and clinical profiles among HIV/HBV co-infected patients in Maputo, MozambiqueLucia Mabalane Chambal, Esperança Sevene, Charlotta Nilsson, et al.
Immunobiology|August 20, 2018
Regulatory T cell abundance and activation status before and after priming with HIVIS-DNA and boosting with MVA-HIV/rgp140/GLA-AF may impact the magnitude of the vaccine-induced immune responsesRaquel Matavele Chissumba, Abílio Luciano, Eduardo Namalango, et al.
Vaccines|July 27, 2022
Vaccine-Induced Seroreactivity Impacts the Accuracy of HIV Testing Algorithms in Sub-Saharan Africa: An Exploratory StudyFrank Msafiri, Alice Manjate, Sarah Lindroth, et al.
BMJ Open|July 19, 2017
Human papillomavirus prevalence and genotype distribution among young women and men in Maputo city, MozambiqueViegas Edna Omar, Augusto Orvalho, Ismael Nália, et al.
Vaccine|May 20, 2009
Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunityLindvi Gudmundsdotter, Charlotta Nilsson, Andreas Brave, et al.
Plos One|June 30, 2015
HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized TrialCharlotta Nilsson, Bo Hejdeman, Karina Godoy-Ramirez, et al.
Vaccines|March 26, 2022
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA VaccinesUlrika Marking, Sebastian Havervall, Nina Greilert-Norin, et al.
Acta Paediatrica (Oslo, Norway : 1992)|April 4, 2026
Signs of Cross-Reactivity Between SARS-CoV-2 and Other Coronaviruses in a Pre-Vaccine Swedish School SettingLina Schollin Ask, Sharon Kühlmann Berenzon, Ulrika Marking, et al.
Vaccines|November 18, 2020
Frequent and Durable Anti-HIV Envelope VIV2 IgG Responses Induced by HIV-1 DNA Priming and HIV-MVA Boosting in Healthy Tanzanian VolunteersAgricola Joachim, Frank Msafiri, Sayali Onkar, et al.
Plos One|April 16, 2015
Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adultsAgricola Joachim, Charlotta Nilsson, Said Aboud, et al.
Pageof 7